Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Diplomat Pharmacy, Inc. (NYSE: DPLO) Securities Case


NEW YORK, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national investor rights law firm, reminds investors that January 9, 2017 is the last day to file lead plaintiff papers in the securities lawsuit against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE:DPLO). The class action is on behalf of a class consisting of all persons who purchased or otherwise acquired Diplomat shares between October 9, 2014 and November 2, 2016 inclusive (the “Class Period”). Diplomat investors are encouraged to go to: http://www.scott-scott.com/cases/new/securities-fraud-litigation-3035-diplomat-pharmacy-inc-dplo.html

Diplomat is a specialty pharmacy that services patients with complex chronic diseases, including the dispensing, delivery, dosing and reimbursement of clinically intensive, high cost specialty drugs. Diplomat’s core revenues are driven by multi-year and life-long patient care to treat chronic conditions including oncology, immunology and hepatitis C, and as a specialty pharmacy the Company is liable for direct and indirect remuneration (“DIR fees”) to government agencies, payors and insurance companies.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls over its financial reporting; (2) as a result the Company could not adequately calculate DIR fees; (3) the Company’s hepatitis C segment was not performing as previously disclosed to investors; (4) and therefore, the Company had overstated its full-year 2016 guidance; and (5) that, as a result of the foregoing, Defendants’ statements about Diplomat’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

What You Can Do

If you purchased Diplomat shares, you may have legal claims against the Company.  If you want to discuss filing lead plaintiff papers, or have questions about your legal rights, please contact attorney Joe Pettigrew at (619) 517-1129, or at jpettigrew@scott-scott.com.

About Scott + Scott, Attorneys at Law, LLP

Scott+Scott has significant experience prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.  The firm has offices in New York, London, Connecticut, California, and Ohio.  Please visit www.scott-scott.com for more information about the firm.



            

Coordonnées